医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models

广告
作者单位: Center for Cancer Research and Therapeutic Development and Department of Biological Sciences,Clark [1] Molecular Oncology and Biomarkers Program, Georgia Cancer Center; Department of Biochemistry and [2] School of Electrical and Computer Engineering, College of Engineering,University of Georgia [3] Emory College of Arts and Sciences [4] Department of Pharmacology and Chemical Biology, and Emory Chemical Biology Discovery Center,Emory [5] Departments of Pathology and Laboratory Medicine,Emory University School of Medicine [6] Department of Urology,Emory University School of Medicine [7]
发布时间 2023-10-24
提交
  • 浏览0
The British journal of cancer

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷